JAZZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $1,435,800.00

Insider Selling (Last 12 Months): $1,567,507.92

Jazz Pharmaceuticals Insider Trading History Chart

Jazz Pharmaceuticals Share Price & Price History

^$120.42

▲ +1.18 (0.99%)

As of 11/21/2024 11:17 AM ET

Days: 30 | 90 | 365

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

From Crypto Swap Profits | Ad

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Jazz Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2024	Neena M. Patil	EVP	Sell	3,700	$123.41	$456,617.00	33,048
11/1/2024	Bruce C. Cozadd	CEO	Sell	1,000	$110.84	$110,840.00	428,976
9/6/2024	Mary Elizabeth Henderson	SVP	Sell	1,410	$108.30	$152,703.00	14,531
6/7/2024	Patricia Carr	CAO	Sell	163	$108.83	$17,739.29	6,596
5/3/2024	Neena M. Patil	EVP	Sell	5,000	$109.65	$548,250.00	36,629
3/6/2024	Patricia Carr	CAO	Sell	1,936	$119.64	$231,623.04	8,364
3/1/2024	Philip L. Johnson	CFO	Buy	12,000	$119.65	$1,435,800.00	27,932
12/4/2023	Mark Douglas Smith	Director	Sell	417	$119.27	$49,735.59	6,888
9/1/2023	Neena M. Patil	EVP	Sell	1,500	$144.25	$216,375.00	29,186
8/29/2023	Patricia Carr	CAO	Sell	142	$143.47	$20,372.74	5,986
8/15/2023	Neena M. Patil	EVP	Sell	750	$139.59	$104,692.50	30,686
8/14/2023	Patricia Carr	CAO	Sell	158	$138.16	$21,829.28	6,128
8/14/2023	Rick E. Winningham	Director	Sell	1,241	$138.16	$171,456.56	10,444
6/7/2023	Patricia Carr	CAO	Sell	126	$127.92	$16,117.92	6,286
6/1/2023	Neena M. Patil	EVP	Sell	1,600	$127.98	$204,768.00	32,826
5/18/2023	Renée D. Galá	CFO	Sell	6,000	$131.75	$790,500.00	35,978
3/15/2023	Patricia Carr	CAO	Sell	1,023	$133.22	$136,284.06	6,286
3/8/2023	Kim Sablich	EVP	Sell	3,013	$139.74	$421,036.62	30,560
3/7/2023	Kenneth W. O'Keefe	Director	Sell	2,690	$138.39	$372,269.10	22,889
3/6/2023	Finbar Larkin	SVP	Sell	1,706	$143.92	$245,527.52	23,854
3/5/2023	Patricia Carr	CAO	Sell	1,148	$140.76	$161,592.48	7,309
2/1/2023	Bruce C. Cozadd	CEO	Sell	1,000	$155.79	$155,790.00	367,078
1/3/2023	Bruce C. Cozadd	CEO	Sell	3,000	$159.86	$479,580.00	368,078
1/3/2023	Samantha Pearce	SVP	Sell	531	$159.59	$84,742.29	11,309
12/21/2022	Renée D. Galá	CFO	Sell	2,635	$160.00	$421,600.00	32,558
12/13/2022	Samantha Pearce	SVP	Sell	531	$155.45	$82,543.95	11,309
12/9/2022	Robert Iannone	EVP	Sell	1,844	$151.54	$279,439.76	36,316
12/5/2022	Patricia Carr	CAO	Sell	63	$152.06	$9,579.78	5,934
12/2/2022	Jennifer E. Cook	Director	Sell	420	$154.68	$64,965.60	5,471
12/1/2022	Bruce C. Cozadd	CEO	Sell	1,000	$157.00	$157,000.00	371,078
11/22/2022	Patrick G. Enright	Director	Sell	4,974	$149.48	$743,513.52	19,112
11/14/2022	Finbar Larkin	SVP	Sell	197	$149.33	$29,418.01	19,409
11/10/2022	Bruce C. Cozadd	CEO	Sell	2,000	$150.00	$300,000.00	372,028
11/10/2022	Samantha Pearce	SVP	Sell	1,063	$155.00	$164,765.00	11,309
10/3/2022	Bruce C. Cozadd	CEO	Sell	45,185	$134.93	$6,096,812.05	374,028
9/7/2022	Finbar Larkin	SVP	Sell	63	$150.00	$9,450.00	19,606
9/6/2022	Bruce C. Cozadd	CEO	Sell	7,703	$153.18	$1,179,945.54	353,311
8/18/2022	Peter Gray	Director	Sell	8,000	$158.00	$1,264,000.00	14,234
8/15/2022	Patricia Carr	CAO	Sell	2,142	$160.06	$342,848.52	5,934
8/4/2022	Samantha Pearce	SVP	Sell	531	$155.00	$82,305.00	11,309
8/1/2022	Bruce C. Cozadd	CEO	Sell	7,301	$154.31	$1,126,617.31	354,311
7/12/2022	Samantha Pearce	SVP	Sell	532	$155.00	$82,460.00	11,309
7/5/2022	Bruce C. Cozadd	CEO	Sell	8,775	$157.28	$1,380,132.00	351,912
7/5/2022	Christopher J. Tovey	COO	Sell	5,209	$160.00	$833,440.00	14,663
6/27/2022	Samantha Pearce	SVP	Sell	8,508	$155.00	$1,318,740.00	11,309
6/8/2022	Samantha Pearce	SVP	Sell	8,487	$155.00	$1,315,485.00	11,309
6/6/2022	Kim Sablich	EVP	Sell	1,388	$152.15	$211,184.20	27,195
6/6/2022	Neena M. Patil	Insider	Sell	1,000	$152.15	$152,150.00	31,600
6/1/2022	Bruce C. Cozadd	CEO	Sell	6,362	$146.87	$934,386.94	351,987
5/11/2022	Patricia Carr	CAO	Sell	722	$147.51	$106,502.22	6,234
5/9/2022	Anne Oriordan	Director	Sell	466	$148.95	$69,410.70	9,245
5/9/2022	Finbar Larkin	SVP	Sell	1,747	$148.94	$260,198.18	19,462
5/9/2022	Patricia Carr	CAO	Sell	1,067	$148.94	$158,918.98	7,229
5/6/2022	Neena M. Patil	Insider	Sell	296	$153.92	$45,560.32	32,677
5/2/2022	Bruce C. Cozadd	CEO	Sell	7,260	$156.63	$1,137,133.80	348,502
4/4/2022	Bruce C. Cozadd	CEO	Sell	10,772	$158.33	$1,705,530.76	346,062
2/1/2022	Bruce C. Cozadd	CEO	Sell	6,372	$139.23	$887,173.56
12/2/2021	Mark Douglas Smith	Director	Sell	417	$121.30	$50,582.10
12/1/2021	Bruce C. Cozadd	CEO	Sell	6,748	$122.66	$827,709.68

2025 AI Stock Picks: 2 Hidden Gems Under $10/Share

From Darwin | Ad

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

👉[Click here to get your FREE report delivered instantly!]

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jazz Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Teachers Retirement System of The State of Kentucky	20,138	$2.24M	0.0%	-81.2%	0.033%
11/18/2024	Coldstream Capital Management Inc.	2,300	$0.26M	0.0%	+7.7%	0.004%
11/16/2024	Geode Capital Management LLC	1,114,778	$124.23M	0.0%	0.0%	1.844%
11/15/2024	MidWestOne Financial Group Inc.	22,063	$2.46M	0.3%	+5.4%	0.036%
11/15/2024	M&T Bank Corp	3,589	$0.40M	0.0%	-17.2%	0.006%
11/15/2024	Barclays PLC	39,210	$4.37M	0.0%	+19.1%	0.065%
11/15/2024	Public Employees Retirement System of Ohio	22,356	$2.49M	0.0%	N/A	0.037%
11/15/2024	Y Intercept Hong Kong Ltd	12,699	$1.42M	0.1%	-47.8%	0.021%
11/15/2024	First National Bank of Omaha	29,987	$3.34M	0.2%	-7.7%	0.050%
11/15/2024	Dean Investment Associates LLC	24,698	$2.75M	0.4%	-3.1%	0.041%
11/15/2024	Orion Portfolio Solutions LLC	22,390	$2.49M	0.1%	-8.1%	0.037%
11/15/2024	XTX Topco Ltd	11,631	$1.30M	0.1%	+57.5%	0.019%
11/15/2024	Krensavage Asset Management LLC	110,257	$12.28M	6.9%	+1.1%	0.182%
11/15/2024	Jane Street Group LLC	132,422	$14.75M	0.0%	-40.3%	0.219%
11/15/2024	Wellington Management Group LLP	44,829	$4.99M	0.0%	-7.7%	0.074%
11/15/2024	Two Sigma Advisers LP	106,000	$11.81M	0.0%	+393.0%	0.175%
11/15/2024	State Street Corp	1,946,273	$216.83M	0.0%	-3.5%	3.219%
11/15/2024	Stifel Financial Corp	142,075	$15.83M	0.0%	+17.0%	0.235%
11/15/2024	Systematic Financial Management LP	283,977	$31.64M	0.8%	+11.7%	0.470%
11/15/2024	Quantinno Capital Management LP	58,913	$6.56M	0.1%	+268.5%	0.097%
11/15/2024	Quarry LP	1,600	$0.18M	0.0%	N/A	0.003%
11/15/2024	Philosophy Capital Management LLC	150,147	$16.73M	1.3%	+11.7%	0.248%
11/15/2024	Point72 Asset Management L.P.	268,783	$29.95M	0.1%	+47.7%	0.445%
11/15/2024	Parkman Healthcare Partners LLC	72,256	$8.05M	1.0%	N/A	0.120%
11/15/2024	Itau Unibanco Holding S.A.	444	$49K	0.0%	+63.2%	0.001%
11/15/2024	HighTower Advisors LLC	7,594	$0.85M	0.0%	+37.2%	0.013%
11/15/2024	Centiva Capital LP	11,632	$1.30M	0.0%	-52.6%	0.019%
11/15/2024	Cinctive Capital Management LP	128,147	$14.28M	0.8%	N/A	0.212%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	14,593	$1.63M	0.3%	+46.4%	0.024%
11/14/2024	ARGA Investment Management LP	12,195	$1.36M	0.0%	+83.9%	0.020%
11/14/2024	Captrust Financial Advisors	4,965	$0.55M	0.0%	+9.5%	0.008%
11/14/2024	Vestal Point Capital LP	900,000	$100.27M	7.6%	-40.0%	1.489%
11/14/2024	Capstone Investment Advisors LLC	2,932	$0.33M	0.0%	N/A	0.005%
11/14/2024	Rockefeller Capital Management L.P.	246,404	$27.45M	0.1%	+1.4%	0.408%
11/14/2024	Martingale Asset Management L P	5,569	$0.62M	0.0%	+190.2%	0.009%
11/14/2024	Isthmus Partners LLC	3,202	$0.36M	0.0%	N/A	0.005%
11/14/2024	Vinva Investment Management Ltd	1,586	$0.18M	0.0%	N/A	0.003%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	174,078	$19.39M	0.0%	+135.3%	0.288%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	11,899	$1.33M	0.0%	+17.0%	0.020%
11/14/2024	Fiduciary Trust Co	6,770	$0.75M	0.0%	+49.6%	0.011%
11/14/2024	National Wealth Management Group LLC	3,358	$0.37M	0.3%	N/A	0.006%
11/14/2024	Stonepine Capital Management LLC	55,000	$6.13M	3.9%	N/A	0.091%
11/14/2024	MetLife Investment Management LLC	31,914	$3.56M	0.0%	-3.7%	0.053%
11/13/2024	Bridgewater Associates LP	112,999	$12.59M	0.1%	+11.7%	0.187%
11/13/2024	Freedom Investment Management Inc.	2,130	$0.24M	0.0%	-4.7%	0.004%
11/13/2024	Townsquare Capital LLC	1,972	$0.22M	0.0%	N/A	0.003%
11/13/2024	BNP Paribas Financial Markets	16,833	$1.88M	0.0%	-99.7%	0.028%
11/13/2024	FMR LLC	835,881	$93.13M	0.0%	-9.5%	1.383%
11/13/2024	The Manufacturers Life Insurance Company	347,752	$38.74M	0.0%	-0.9%	0.575%
11/13/2024	Bank of Montreal Can	19,447	$2.16M	0.0%	-71.7%	0.032%
11/13/2024	Loomis Sayles & Co. L P	106,652	$11.88M	0.0%	+2.7%	0.176%
11/13/2024	Daiwa Securities Group Inc.	237	$26K	0.0%	-71.7%	0.000%
11/12/2024	Cerity Partners LLC	32,757	$3.65M	0.0%	+128.4%	0.053%
11/12/2024	Valence8 US LP	8,969	$1M	0.4%	N/A	0.015%
11/12/2024	Charles Schwab Investment Management Inc.	531,710	$59.24M	0.0%	+8.7%	0.861%
11/12/2024	Pacer Advisors Inc.	2,099,378	$233.89M	0.5%	+15.3%	3.400%
11/12/2024	Thompson Siegel & Walmsley LLC	781,215	$87.04M	1.3%	+8.3%	1.265%
11/9/2024	John G Ullman & Associates Inc.	45,094	$5.02M	0.7%	-20.2%	0.073%
11/9/2024	Foundry Partners LLC	3,362	$0.38M	0.0%	+10.9%	0.005%
11/9/2024	Intech Investment Management LLC	6,639	$0.74M	0.0%	-47.0%	0.011%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	429,077	$47.80M	0.1%	-2.1%	0.695%
11/8/2024	Ontario Teachers Pension Plan Board	7,098	$0.79M	0.0%	-22.7%	0.011%
11/8/2024	Advisors Asset Management Inc.	9,624	$1.07M	0.0%	+3.9%	0.016%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	18,633	$2.08M	0.0%	-21.5%	0.030%
11/7/2024	Swiss National Bank	117,000	$13.04M	0.0%	+0.3%	0.189%
11/7/2024	Thrivent Financial for Lutherans	14,619	$1.63M	0.0%	-44.2%	0.024%
11/6/2024	Mutual of America Capital Management LLC	33,377	$3.72M	0.0%	-7.5%	0.054%
11/6/2024	Natixis Advisors LLC	22,834	$2.54M	0.0%	+7.6%	0.037%
11/6/2024	CIBC Asset Management Inc	1,875	$0.21M	0.0%	N/A	0.003%
11/6/2024	OneDigital Investment Advisors LLC	2,629	$0.29M	0.0%	-6.5%	0.004%
11/6/2024	KBC Group NV	228,304	$25.44M	0.1%	-39.6%	0.370%
11/6/2024	Kovack Advisors Inc.	57,672	$6.43M	0.7%	+20.4%	0.093%
11/6/2024	Oppenheimer Asset Management Inc.	7,721	$0.86M	0.0%	-1.6%	0.013%
11/6/2024	MQS Management LLC	2,270	$0.25M	0.1%	N/A	0.004%
11/5/2024	Victory Capital Management Inc.	253,299	$28.22M	0.0%	+23.3%	0.410%
11/5/2024	American Assets Inc.	5,000	$0.56M	0.2%	N/A	0.008%
11/4/2024	Venturi Wealth Management LLC	826	$92K	0.0%	+577.0%	0.001%
11/4/2024	Los Angeles Capital Management LLC	5,606	$0.63M	0.0%	N/A	0.009%
11/4/2024	State of New Jersey Common Pension Fund D	23,662	$2.64M	0.0%	-5.9%	0.038%
11/4/2024	Meritage Portfolio Management	80,607	$8.98M	0.6%	-0.9%	0.131%
11/4/2024	Crossmark Global Holdings Inc.	5,083	$0.57M	0.0%	+23.6%	0.008%
11/2/2024	Covestor Ltd	1,100	$0.12M	0.1%	-8.8%	0.002%
11/1/2024	CWA Asset Management Group LLC	28,693	$3.20M	0.2%	N/A	0.046%
11/1/2024	Philip James Wealth Mangement LLC	7,454	$0.83M	0.1%	N/A	0.012%
10/31/2024	Principal Financial Group Inc.	142,938	$15.93M	0.0%	-31.9%	0.231%
10/30/2024	Radnor Capital Management LLC	7,980	$0.89M	0.1%	-3.0%	0.013%
10/30/2024	Amalgamated Bank	29,444	$3.28M	0.0%	-24.7%	0.047%
10/30/2024	AlphaCentric Advisors LLC	15,500	$1.73M	1.3%	+40.9%	0.025%
10/29/2024	Robeco Institutional Asset Management B.V.	167,356	$18.65M	0.0%	-10.3%	0.265%
10/29/2024	Van ECK Associates Corp	60,211	$6.69M	0.0%	+11.4%	0.095%
10/29/2024	Janney Montgomery Scott LLC	10,266	$1.14M	0.0%	-6.0%	0.016%
10/28/2024	Stephens Inc. AR	5,563	$0.62M	0.0%	+16.1%	0.009%
10/25/2024	First Trust Direct Indexing L.P.	1,917	$0.21M	0.0%	-35.3%	0.003%
10/25/2024	New York State Teachers Retirement System	43,318	$4.83M	0.0%	-0.9%	0.069%
10/25/2024	China Universal Asset Management Co. Ltd.	11,877	$1.32M	0.1%	+60.4%	0.019%
10/24/2024	Tributary Capital Management LLC	4,040	$0.45M	0.0%	-4.7%	0.006%
10/24/2024	Ellis Investment Partners LLC	5,813	$0.65M	0.1%	-1.9%	0.009%
10/24/2024	State of Alaska Department of Revenue	33,173	$3.70M	0.0%	+387.6%	0.053%
10/24/2024	DekaBank Deutsche Girozentrale	115,130	$12.64M	0.0%	+37.3%	0.183%
10/24/2024	Wealth Enhancement Advisory Services LLC	3,359	$0.37M	0.0%	-5.4%	0.005%

Data available starting January 2016

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

Today's Range

Now: $120.42

$120.07

$122.03

50 Day Range

MA: $112.92

$106.45

$127.74

52 Week Range

Now: $120.42

$99.06

$134.17

Volume

81,700 shs

Average Volume

674,492 shs

Market Capitalization

$7.28 billion

P/E Ratio

16.96

Dividend Yield

N/A

Beta

0.57

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top insider shareholders include:
Bruce C Cozadd (CEO)
Neena M Patil (EVP)
Robert Iannone (EVP)
Renee D Gala (CFO)
Kim Sablich (EVP)
Philip L Johnson (CFO)
Finbar Larkin (SVP)
Kenneth W O'keefe (Director)
Patrick G Enright (Director)
Mary Elizabeth Henderson (SVP)
Samantha Pearce (SVP)
Rick E Winningham (Director)
Patricia Carr (CAO)
Mark Douglas Smith (Director)
Jennifer E Cook (Director)
Learn More about top insider investors at Jazz Pharmaceuticals.
Who are the major institutional investors of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top institutional investors include:
Pacer Advisors Inc. — 3.40%
State Street Corp — 3.22%
Geode Capital Management LLC — 1.84%
Vestal Point Capital LP — 1.49%
FMR LLC — 1.38%
Thompson Siegel & Walmsley LLC — 1.27%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.
Which major investors are selling Jazz Pharmaceuticals stock?: Within the previous quarter, JAZZ stock was sold by these institutional investors:
BNP Paribas Financial Markets
Vestal Point Capital LP
KBC Group NV
Jane Street Group LLC
FMR LLC
Teachers Retirement System of The State of Kentucky
State Street Corp
Principal Financial Group Inc.
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
Bruce C Cozadd (CEO)
Neena M Patil (EVP)
Robert Iannone (EVP)
Renee D Gala (CFO)
Kim Sablich (EVP)
Learn More investors selling Jazz Pharmaceuticals stock.
Which major investors are buying Jazz Pharmaceuticals stock?: During the last quarter, JAZZ stock was acquired by institutional investors including:
Wedge Capital Management L L P NC
Pacer Advisors Inc.
Cinctive Capital Management LP
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Point72 Asset Management L.P.
Two Sigma Advisers LP
Parkman Healthcare Partners LLC
Perpetual Ltd